Modified Citrus Pectin And Cancer

There is growing evidence suggesting that MCP has powerful cancer fighting mechanisms. In one study, researchers concluded that MCP inhibits cancer cells from combining to form tumors in areas of the body outside the primary tumor, causing cancer cells to commit cell suicide.1 MCP demonstrates characteristics that may even prevent cancer cells from forming into a tumor in the first place.

Additionally, “MCP has been shown to be effective against prostate carcinoma, colon carcinoma, breast carcinoma, melanoma, multiple myeloma, and hemangiosarcoma [canine blood vessel cancer].”2   These same researchers also contend that even though there are limited studies on humans, one human study of MCP indicated that it significantly prohibited the progression of prostate cancer and doubled the survival time of recurrent prostate cancer patients.3

At an American Chemical Society Symposium, Doctor Isaac Eliaz presented an extensive summary on the anticancer mechanisms of MCP. Most notably, he pointed out that there exists substantial scientific evidence that MCP prevents angiogenesis, which means it blocks the ability of cancer cells to form new blood vessels. MCP also helps remove heavy metals from the body without affecting essentialvminerals.4

MCP has emerged as an extremely promising substance that can inhibit cancer cells from forming into tumors and also prevent its spread to other areas of the body. Based on the Author’s experience, in a preventive context, doses are sited by various alternative practitioners as ranging from a minimum of 3 to 5 grams per day.  In a context of preventing recurrence, after completing cancer treatment, the recommended daily dose goes up to 10 grams per day.  The author found it very easy to take 5 grams, twice daily, by mixing the power in applesauce, and experienced no side effects, and used PectaSol-C, produced by EcoNugenics.

 

 

Notes:

1. Vladislav V. Glinsky and Avraham Raz. “Modified Citrus Pectin Anti-Metastatic Properties: One Bullet, Multiple Targets,”Carbohydr Res. 2009 Sep 28: 344(14): 1788-1791, Conclusions. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782490

2. Ibid., 1.

3. Ibid., 5.

4. “American Chemical Society Highlights Modified Citrus Pectin as Solution to Chronic Disease Marker Galectin-3.” Better Health Publishing, 22-Aug-2012.http://www.newswise.com/articles/american-chemical-society- highlights-modified-citrus-pectin-as-solution-to-chronic-disease-marker-galectin-3

© 2018 Joseph Marx. All Rights Reserved. Powered by HostBaby.